Transactions in connection with share buy-back program
Company Announcement
COPENHAGEN, Denmark; May31, 2021 Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.
The share buy-back program is expected to be completed no later than June 30, 2021 and comprises up to 200,000 shares.
The following transactions were executed under the program from May 24, 2021 to May 28, 2021:
| No. of shares … |
